Exparel 266 MG/20 ML vial 20ML
Ended Awarded
- Contract number
- SPE2DB25FX2AA
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $20,085
Award facts
- Contract value 100% obligated
- $20,085.04 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
On July 18, 2025, the Defense Logistics Agency (DLA) awarded a delivery order valued at approximately $20.1K to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The delivery order covers the supply of EXPAREL 266 mg/20 mL vials, a liposomal bupivacaine formulation used for post-operative pain management. This firm fixed-price delivery order is expected to reach completion by August 8, 2025, with performance occurring at the awardee's Park Ridge facility. No set-aside designation was applied to this contract award.
This delivery order was issued under DMS Pharmaceutical Group's existing single-award Indefinite Delivery Contract with the DLA under the SPE2DB program, a $499.9 billion contract vehicle valid through November 2026 that enables the agency to procure a comprehensive range of pharmaceutical products and medical supplies for military health facilities worldwide. DMS Pharmaceutical Group has established itself as a critical supplier within the federal pharmaceutical supply chain, consistently delivering specialty medications, biologics, and medical consumables to Department of Defense healthcare sites. The company's federal contracting history demonstrates sustained engagement with DLA across diverse pharmaceutical product categories, positioning it as a reliable distributor for military medical supply requirements.
Quick answers
Who was awarded contract SPE2DB25FX2AA?
SPE2DB25FX2AA was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on July 18, 2025.
How much is contract SPE2DB25FX2AA worth?
The government has obligated $20,085 on SPE2DB25FX2AA.
Is contract SPE2DB25FX2AA an order under another contract?
Yes. SPE2DB25FX2AA is a delivery order under SPE2DB22D9353, an indefinite delivery contract.
Was contract SPE2DB25FX2AA competed?
The extent of competition for SPE2DB25FX2AA was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award